Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 | Starlite/ChEMBL | References |
Homo sapiens | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | neutral amino acid transporter A | 0.0457 | 0 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0457 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0999 | 1 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter | 0.0457 | 0 | 0.5 |
Echinococcus granulosus | neutral amino acid transporter A | 0.0457 | 0 | 0.5 |
Echinococcus multilocularis | sodium:dicarboxylate symporter | 0.0457 | 0 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.0457 | 0 | 0.5 |
Schistosoma mansoni | solute carrier family 1 (glial high affinity glutamate transporter | 0.0457 | 0 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.0457 | 0 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0999 | 1 | 0.5 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.0457 | 0 | 0.5 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0999 | 1 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 3 | 0.0457 | 0 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0457 | 0 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0999 | 1 | 1 |
Onchocerca volvulus | Excitatory amino acid transporter homolog | 0.0457 | 0 | 0.5 |
Echinococcus granulosus | Excitatory amino acid transporter | 0.0457 | 0 | 0.5 |
Echinococcus multilocularis | neutral amino acid transporter A | 0.0457 | 0 | 0.5 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.0457 | 0 | 0.5 |
Echinococcus multilocularis | Excitatory amino acid transporter | 0.0457 | 0 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 3 | 0.0457 | 0 | 0.5 |
Loa Loa (eye worm) | excitatory amino acid transporter | 0.0457 | 0 | 0.5 |
Echinococcus granulosus | sodium:dicarboxylate symporter | 0.0457 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0999 | 1 | 1 |
Echinococcus multilocularis | neutral amino acid transporter excitatory amino acid transporter | 0.0457 | 0 | 0.5 |
Brugia malayi | Excitatory amino acid transporter | 0.0457 | 0 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0999 | 1 | 0.5 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0999 | 1 | 0.5 |
Echinococcus granulosus | excitatory amino acid transporter 2 | 0.0457 | 0 | 0.5 |
Echinococcus multilocularis | excitatory amino acid transporter 2 | 0.0457 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.2 uM | Inhibitory concentration against glutamate uptake in HEK cells expressing human Excitatory amino acid transporter 1 | ChEMBL. | 16165356 |
IC50 (binding) | = 0.3 uM | Inhibitory concentration against glutamate uptake in HEK cells expressing human Excitatory amino acid transporter 2 | ChEMBL. | 16165356 |
IC50 (binding) | = 0.45 uM | Inhibitory concentration against glutamate uptake in HEK cells expressing human Excitatory amino acid transporter 3 | ChEMBL. | 16165356 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.